Michael E. Miller

1.0k total citations
18 papers, 809 citations indexed

About

Michael E. Miller is a scholar working on Immunology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael E. Miller has authored 18 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 6 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael E. Miller's work include Immunodeficiency and Autoimmune Disorders (5 papers), Blood disorders and treatments (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Michael E. Miller is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (5 papers), Blood disorders and treatments (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Michael E. Miller collaborates with scholars based in United States and Spain. Michael E. Miller's co-authors include Ulf Nilsson, Henry Daniell, Angel M. Mingo‐Castel, Alan K. Percy, Alicia Fernández‐San Millán, Michael E. Norman, Peter J. Koblenzer, Anthony Cheung, Irwin Κ. M. Liu and M. Bernoco and has published in prestigious journals such as Nature, New England Journal of Medicine and The Journal of Immunology.

In The Last Decade

Michael E. Miller

16 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Miller United States 11 340 245 115 112 101 18 809
Frederic G. Dalldorf United States 17 176 0.5× 280 1.1× 59 0.5× 37 0.3× 117 1.2× 30 981
P. B. Dent Canada 18 419 1.2× 248 1.0× 148 1.3× 26 0.2× 150 1.5× 55 1.1k
Tsue-Ming Lin United States 13 123 0.4× 216 0.9× 128 1.1× 26 0.2× 50 0.5× 35 922
J W Larrick United States 12 319 0.9× 373 1.5× 69 0.6× 18 0.2× 94 0.9× 17 855
G. L. Asherson United Kingdom 17 793 2.3× 288 1.2× 82 0.7× 16 0.1× 124 1.2× 58 1.3k
J E Carty United Kingdom 8 1.0k 3.0× 178 0.7× 34 0.3× 40 0.4× 59 0.6× 11 1.5k
S. J. Thompson United Kingdom 14 175 0.5× 267 1.1× 35 0.3× 24 0.2× 47 0.5× 23 604
Debra D. Hiraki United States 7 573 1.7× 130 0.5× 115 1.0× 22 0.2× 43 0.4× 12 897
Elizabeth Fischer France 18 387 1.1× 111 0.5× 79 0.7× 20 0.2× 46 0.5× 34 940
Rick de Waard Netherlands 9 492 1.4× 311 1.3× 41 0.4× 18 0.2× 66 0.7× 9 1.1k

Countries citing papers authored by Michael E. Miller

Since Specialization
Citations

This map shows the geographic impact of Michael E. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Miller more than expected).

Fields of papers citing papers by Michael E. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Miller. The network helps show where Michael E. Miller may publish in the future.

Co-authorship network of co-authors of Michael E. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Miller. A scholar is included among the top collaborators of Michael E. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Miller. Michael E. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Millán, Alicia Fernández‐San, Angel M. Mingo‐Castel, Michael E. Miller, & Henry Daniell. (2003). A chloroplast transgenic approach to hyper‐express and purify Human Serum Albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnology Journal. 1(2). 71–79. 152 indexed citations
2.
Miller, Michael E., et al.. (1989). Adherence assay of 51chromium-labeled human polymorphonuclear leukocyte using glass beads. Journal of Immunological Methods. 124(1). 29–33. 6 indexed citations
3.
Bernoco, M., et al.. (1987). Chemotactic and phagocytic function of peripheral blood polymorphonuclear leucocytes in newborn foals.. PubMed. 35. 599–605. 23 indexed citations
4.
Cheung, Anthony, et al.. (1985). Phagocytic and killing capacities of uterine-derived polymorphonuclear leukocytes from mares resistant and susceptible to chronic endometritis. American Journal of Veterinary Research. 46(9). 1938–1940. 52 indexed citations
5.
Miller, Michael E.. (1978). 719 CELL ELASTIMETRY IN THE CHARACTERIZATION OF DISORDERS OF NEUTROPHIL MOTILITY. Pediatric Research. 12. 483–483.
6.
Miller, Michael E.. (1978). Current Topics in Host Defenses of the Newborn. Advances in Pediatrics. 25(1). 59–95. 3 indexed citations
7.
Miller, Michael E.. (1977). Host Defenses in the Human Neonate. Pediatric Clinics of North America. 24(2). 413–423. 52 indexed citations
8.
Miller, Michael E. & Laurence A. Boxer. (1977). CELL ELASTIMETRY IN THE DETECTION OF IMMUNE NEUTROPENIA - - DEMONSTRATION OF A MEMBRANE PERTURBATION. Pediatric Research. 11(4). 477–477. 2 indexed citations
9.
Miller, Michael E.. (1977). Disorders of neutrophil function. American Journal of Hematology. 3(4). 257–261. 1 indexed citations
10.
Percy, Alan K. & Michael E. Miller. (1975). Reduced deformability of erythrocyte membranes from patients with Duchenne muscular dystrophy. Nature. 258(5531). 147–148. 76 indexed citations
11.
Miller, Michael E. & Ulf Nilsson. (1974). A major role of the fifth component of complement (C5) in the opsonization of yeast particles. Partial dichotomy of function and immunochemical measurement. Clinical Immunology and Immunopathology. 2(2). 246–255. 24 indexed citations
12.
Nilsson, Ulf, et al.. (1974). A Functional Abnormality of the Fifth Component of Complement (C5) from Human Serum of Individuals with a Familial Opsonic Defect. The Journal of Immunology. 112(3). 1164–1176. 29 indexed citations
13.
Miller, Michael E.. (1973). Uses and abuses of plasma therapy in the patient with recurrent infections. Journal of Allergy and Clinical Immunology. 51(1). 45–56. 8 indexed citations
14.
Miller, Michael E., et al.. (1973). A new familial defect of neutrophil movement.. PubMed. 82(1). 1–8. 56 indexed citations
15.
Miller, Michael E.. (1973). Neonatal Immunology and Related Protective Mecha. CRC Critical Reviews in Clinical Laboratory Sciences. 4(1). 1–18. 1 indexed citations
16.
Miller, Michael E.. (1970). Enhanced Susceptibility to Infection. Medical Clinics of North America. 54(3). 713–722. 12 indexed citations
17.
Miller, Michael E. & Ulf Nilsson. (1970). A Familial Deficiency of the Phagocytosis-Enhancing Activity of Serum Related to a Dysfunction of the Fifth Component of Complement (C5). New England Journal of Medicine. 282(7). 354–358. 194 indexed citations
18.
Miller, Michael E.. (1969). Phagocytosis in the newborn infant: Humoraland cellular factors. The Journal of Pediatrics. 74(2). 255–259. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026